Bull
$709.68
Scenario price
$513.180
+12.727 (+2.48%)At close
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
Chemed Corp is currently a hold. The stock is priced at $499.82, with a median analyst price target of $549, suggesting a potential upside of 9.8%. However, the RSI is at 37.844, indicating it is approaching oversold territory, which may present a buying opportunity if it stabilizes. The main risk is the insider selling, with an executive recently reducing holdings by 7%, which could signal caution among insiders.
UBS
$650
2026-09-25
UBS
2026-09-25
Price Target
$650
Oppenheimer
$590
2026-07-31
Oppenheimer
2026-07-31
Price Target
$590
RBC Capital
$548
2026-07-30
RBC Capital
2026-07-30
Price Target
$548
BofA
$510
2026-07-09
BofA
2026-07-09
Price Target
$510
RBC Capital
$436
2026-04-27
RBC Capital
2026-04-27
Price Target
$436
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Key Wall Street Calls on Friday

Chemed Executive Sells 1,000 Shares, Reducing Holdings by 7%

Chemed Executive Sells Shares, Reducing Holdings by 7%

Chemed Corp Options Trading Activity Surges

Biotech Stocks Reach 52-Week Highs Driven by Strong Earnings
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Chemed Corp is currently a hold. The stock is priced at $499.82, with a median analyst price target of $549, suggesting a potential upside of 9.8%. However, the RSI is at 37.844, indicating it is approaching oversold territory, which may present a buying opportunity if it stabilizes. The main risk is the insider selling, with an executive recently reducing holdings by 7%, which could signal caution among insiders.
4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.